PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Optimizing Glycemic Control With GLP-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Risk: Translating the Evidence to Practice
Visit https://www.peervoice.com/GHP860 to view the entire programme with slides. After completing “Optimizing Glycemic Control With GLP-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Risk: Translating the Evidence to Practice”, participants will be able to: Apply clinical practice guidelines to optimize early initiation of GLP-1 receptor agonists (RAs) in patients with type 2 diabetes (T2D) and cardiovascular (CV) risk; Outline practical patient management considerations with GLP-1 RAs such as dosing, side effects, and use in special populations; and Identify factors contributing to clinical inertia and how they may be addressed in patients with T2D and CV risk.